Keyphrases
Chronic Kidney Disease
67%
Intact Parathyroid Hormone (iPTH)
55%
Post-transplant Lymphoproliferative Disorder
44%
Kidney
42%
Pediatric
36%
Kidney Transplant
32%
Osteoclast
30%
Pediatric Kidney Transplantation
30%
Kidney Transplantation
29%
Ca2+
26%
Vascular Calcification
25%
Pediatric Nephrology
21%
Immunosuppression
20%
Bone Morphogenetic protein-7 (BMP-7)
20%
Osteopontin
17%
Hypertension
17%
CKD-MBD
16%
Renal Transplantation
16%
Midwest
15%
Cytosolic Calcium
15%
Transplantation
15%
Renal Transplant Recipients
15%
Kidney Transplant Recipients
15%
Acute Rejection
14%
Kidney Disease
14%
Older Adults
14%
Risk Factors
13%
Acute Kidney Injury
13%
Continuous Renal Replacement Therapy
13%
Pretransplant
13%
Osteoblast
13%
Bone Resorption
12%
Pediatric Patients
12%
End-stage Renal Disease
12%
North America
12%
Pediatric Dialysis
12%
Integrin
12%
Renal Osteodystrophy
12%
Hemodialysis
11%
Estimated Glomerular Filtration Rate
11%
Solid Organ Transplantation
11%
African American
11%
Renal Tubular Epithelial Cells
11%
Pediatric Kidney Transplant Recipients
11%
1,25(OH)2D3
11%
Dialysis
11%
High Risk
11%
United States
10%
Epstein-Barr Virus
10%
Kidney Function
10%
Na +
10%
Serum Creatinine
10%
Graft Survival
10%
Phosphate
9%
Transplant Recipients
9%
Blood Pressure
9%
Confidence Interval
9%
Adjusted Hazard Ratio
9%
Renal Injury
9%
Bone Disorders
9%
Liver
9%
Vitamin D
9%
Diabetes
9%
Hyperphosphatemia
9%
Osteoblast Cells
8%
Onasemnogene Abeparvovec
8%
Phosphorus
8%
Nephrotic Syndrome
8%
Canine
8%
Renal Transplant
8%
Glomerular Filtration Rate
8%
Elastin
8%
Epidemiology
8%
Patient Survival
8%
Allograft Survival
8%
Lupus Nephritis
7%
BK Polyomavirus (BKPyV)
7%
Cardiovascular Risk
7%
Fibroblast Growth Factor 23 (FGF23)
7%
Phosphate Transport
7%
Creatinine
7%
Type 2 Diabetes Mellitus (T2DM)
7%
First Year
7%
Brush Border Membrane Vesicles
7%
Bone Mineral Density
7%
Hemodialysis Patients
7%
Knock-in Mouse Model
7%
Podosome
7%
Vasculature
7%
Viral Infection
7%
Graft Failure
6%
Pathophysiology
6%
Cystatin C (Cys C)
6%
Chronic Renal Disease
6%
Secondary Hyperparathyroidism
6%
Plasma Membrane
6%
Vascular Access
6%
Cyclic Adenosine Monophosphate (cAMP)
6%
Pediatric Population
6%
Hospitalization
6%
Medicine and Dentistry
Pediatrics
100%
Chronic Kidney Disease
70%
Kidney Graft
56%
Transplantation
54%
Kidney Transplantation
52%
Posttransplant Lymphoproliferative Disease
38%
Parathyroid Hormone
31%
Nephropathy
26%
Immunosuppressive Treatment
25%
Blood Vessel Calcification
22%
Isotopes of Calcium
21%
Bone Disease
21%
Pediatric Nephrology
21%
Infection
20%
Diseases
18%
Acute Kidney Injury
18%
Adolescence
17%
Hemodialysis
17%
Calcium Ion
17%
Osteoblast
16%
End Stage Renal Disease
16%
Kidney Function
15%
Osteogenic Protein 1
14%
Graft Survival
13%
Continuous Renal Replacement Therapy
12%
Creatinine
11%
Pediatrics Patient
11%
Blood Pressure
11%
Solid Organ Transplantation
11%
Epstein Barr Virus
11%
Glomerular Filtration Rate
11%
Allograft
10%
Acute Graft Rejection
10%
Cohort Analysis
10%
Diabetes
10%
Nephrotic Syndrome
9%
Graft Failure
9%
Biopsy Technique
9%
In Vitro
9%
Biological Marker
8%
Hyperphosphatemia
8%
Kidney Injury
8%
Health Care Cost
8%
Cardiovascular Risk
8%
Glomerulopathy
8%
Bone Density
7%
Pathophysiology
7%
Renal Osteodystrophy
7%
Osteopontin
7%
Chronic Kidney Disease-Mineral and Bone Disorder
7%
Osteoclast
7%
Hazard Ratio
7%
Vascular Access
7%
Ossification
7%
Fibroblast Growth Factor 23
7%
BK Virus
7%
Medicare
7%
Renal Replacement
6%
Mineralization
6%
Elastin
6%
Lupus Nephritis
6%
Renal Replacement Therapy
6%
Cardiovascular System
6%
Maturity Onset Diabetes of the Young
6%
Renal Failure
6%
Prevalence
6%
Cohort Effect
6%
Bone Remodeling
6%
Arteriovenous Fistula
6%
Thymocyte Antibody
6%
Tacrolimus
6%
Urinary Tract Infection
6%
Cardiovascular Disease
6%
Immunosuppressive Drug
6%
Proteinuria
6%
Cancer
5%
Intensive Care Unit
5%
Receptor
5%
Osteolysis
5%
Vascularity
5%
Peritoneal Dialysis
5%
Skeleton
5%
Calcitriol
5%
Osteodystrophy
5%
Lung
5%